![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ci6748contents.gif)
Acta Cryst. (2006). E62, o592-o594 [ doi:10.1107/S1600536806000705 ]
Abstract: The title compound, (E)-3-{2-[3-(2-bromophenyl)-6a,10b-dimethyl-8-methyleneperhydronaphtho[2,1-d][1,3]dioxin-7-yl]ethylidene}-4-hydroxy-4,5-dihydrofuran-2(3H)-one, C27H33BrO5, an andrographolide derivative, was semi-synthesized using andrographolide as a starting material. The structure contains three fused six-membered rings adopting chair conformations and a five-membered ring adopting an envelope conformation. The 2-bromophenyl group is twisted away from the attached ring. O-H
O hydrogen bonds in the structure form chains along the b axis which are interlinked via C-H
O interactions.
Online 13 January 2006
Copyright © International Union of Crystallography
IUCr Webmaster